Citations

Citations to this article as recorded by  

• Tailored point-of-care biosensors for liquid biopsy in the field of oncology
  Sima Singh, Pritam Saha Podder, Matt Russo, Charles Henry, Stefano Cinti
  Lab on a Chip.2023; 23(1): 44.     CrossRef
• Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer
  Akash Bararia, Prosenjeet Chakraborty, Paromita Roy, Bitan Kumar Chattopadhay, Amlan Das, Aniruddha Chatterjee, Nilabja Sikdar
  World Journal of Gastroenterology.2023; 29(15): 2241.     CrossRef
• Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspects
  Gabriela Fernandes, Ana Rodrigues, Cláudia Matos, Fernando Barata, Luís Cirnes, Lurdes Ferreira, José Albino Lopes, Margarida Felizardo, Paula Fidalgo, Ulisses Brito, Bárbara Parente
  Cancer Treatment and Research Communications.2023; 36: 100725.     CrossRef
• Tweezer PCR: A Highly Specific Method for Accurate Identification of Low-Abundance Mutations
  Shanglin Li, Yin Gu, Zhi Geng, Kaiyi Li, Yawei Hu, Qiang Liu, Rongxin Fu, Peng Liu
  Analytical Chemistry.2023; 95(48): 17679.     CrossRef
• Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics
  Hyun Hee Koh, Eunhyang Park, Hyun-Soo Kim
  Diagnostics.2022; 12(2): 326.     CrossRef
• Alveolar Soft Part Sarcoma of the Uterus: Clinicopathological and Molecular Characteristics
  Yurimi Lee, Kiyong Na, Ha Young Woo, Hyun-Soo Kim
  Diagnostics.2022; 12(5): 1102.     CrossRef
• Exosomal MicroRNA Analyses in Esophageal Squamous Cell Carcinoma Cell Lines
  Sora Kim, Gwang Ha Kim, Su Jin Park, Chae Hwa Kwon, Hoseok I, Moon Won Lee, Bong Eun Lee
  Journal of Clinical Medicine.2022; 11(15): 4426.     CrossRef
• Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
  Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee
  Journal of Pathology and Translational Medicine.2021; 55(3): 181.     CrossRef
• Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer
  Pamela Abdayem, David Planchard
  European Respiratory Review.2021; 30(161): 200294.     CrossRef
• Dynamics of Specific cfDNA Fragments in the Plasma of Full Marathon Participants
  Takehito Sugasawa, Shin-ichiro Fujita, Tomoaki Kuji, Noriyo Ishibashi, Kenshirou Tamai, Yasushi Kawakami, Kazuhiro Takekoshi
  Genes.2021; 12(5): 676.     CrossRef
• Future Perspectives in Detecting EGFR and ALK Gene Alterations in Liquid Biopsies of Patients with NSCLC
  Daniela Ferreira, Juliana Miranda, Paula Martins-Lopes, Filomena Adega, Raquel Chaves
  International Journal of Molecular Sciences.2021; 22(8): 3815.     CrossRef
• Real-World Analysis of the EGFR Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer
  Hyunwoo Lee, Joungho Han, Yoon-La Choi
  Diagnostics.2021; 11(9): 1695.     CrossRef
• Objective Quantitation of EGFR Protein Levels using Quantitative Dot Blot Method for the Prognosis of Gastric Cancer Patients
  Lei Xin, Fangrong Tang, Bo Song, Maozhou Yang, Jiandi Zhang
  Journal of Gastric Cancer.2021; 21(4): 335.     CrossRef
• The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer
  D. Akhoundova, J. Mosquera Martinez, L. E. Musmann, C. Britschgi, C. Rütsche, M. Rechsteiner, E. Nadal, M. R. Garcia Campelo, A. Curioni-Fontecedro
  Journal of Clinical Medicine.2020; 9(11): 3674.     CrossRef
• Expanding opportunities in precision oncology
  T Raja
  Cancer Research, Statistics, and Treatment.2020; 3(4): 863.     CrossRef